ダウンロード数: 780

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
15_0587.pdf498.21 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.author石神, 襄次ja
dc.contributor.author原, 信二ja
dc.contributor.author三田, 俊彦ja
dc.contributor.author福田, 泰久ja
dc.contributor.alternativeIshigami, Jojien
dc.contributor.alternativeHara, Shinjien
dc.contributor.alternativeMita, Toshihikoen
dc.contributor.alternativeFukuda, Yasuhisaen
dc.date.accessioned2010-06-02T06:18:37Z-
dc.date.available2010-06-02T06:18:37Z-
dc.date.issued1969-08-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/120029-
dc.description.abstract1) Clinical results: Cephalexin (Lilly) was administered to 31 patients with urinary tract infection. Excellent result was seen in 21, fair 4, no effect 5, and one was lost from our clinic. Overall effectiveness was 83.3% in percentage. 2) Blood levels: The highest blood level of cephalexin after administration in dosage of 0.5 or 1.0g was observed in one hour. After that, the level continued to decraese for other three hours. 3) Urinary excretion: After oral administration of 1.0g cephalexin, more than 80 % of it was excreted in urine within 6 hours. 4) Antimicrobial potency: The potency of CEX against Staphylococcus, E. coli, Proteus and Klebsiella was 1/2 to 1/4 of CER. 5) Side effect: Only one of 31 patients complained of abdominal discomfort.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher京都大学医学部泌尿器科学教室ja
dc.publisher.alternativeDepartment of Urology, Faculty of Medicine, Kyoto Univeersityen
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAmpicillin/pharmacologyen
dc.subjectCephaloridine/pharmacologyen
dc.subjectCephalosporins/administration & dosage/blood/therapeutic use/urineen
dc.subjectChilden
dc.subjectChild, Preschoolen
dc.subjectCloxacillin/pharmacologyen
dc.subjectEscherichia coli/drug effectsen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectKanamycin/pharmacologyen
dc.subjectKlebsiella/drug effectsen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectProteus/drug effectsen
dc.subjectStaphylococcus/drug effectsen
dc.subjectTetracycline/pharmacologyen
dc.subjectTime Factorsen
dc.subjectUrinary Tract Infections/drug therapyen
dc.subject.ndc494.9-
dc.title泌尿器科領域におけるCephalexinの応用ja
dc.title.alternativeCephalexin for urinary tract infectionen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume15-
dc.identifier.issue8-
dc.identifier.spage587-
dc.identifier.epage595-
dc.textversionpublisher-
dc.sortkey08-
dc.address神戸大学医学部泌尿器科学教室ja
dc.address.alternativeThe Department of Urology, Kobe University School of Medicineen
dc.identifier.pmid4899651-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.15 No.8

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。